{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:54:23Z","timestamp":1785851663496,"version":"3.56.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,9,27]]},"DOI":"10.1097\/01.tp.0000134399.10352.e4","type":"journal-article","created":{"date-parts":[[2004,9,20]],"date-time":"2004-09-20T04:07:41Z","timestamp":1095653261000},"page":"904-910","source":"Crossref","is-referenced-by-count":46,"title":["The Selective Use of Basiliximab Versus Thymoglobulin in Combination with Sirolimus for Cadaveric Renal Transplant Recipients at Low Risk Versus High Risk for Delayed Graft Function"],"prefix":"10.1097","volume":"78","author":[{"given":"Richard J.","family":"Knight","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald H.","family":"Kerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Schoenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemangshu","family":"Podder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles T.","family":"Van Buren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry D.","family":"Kahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20210129","article-title":"Clinical Transplants 2001, vol 1.","author":"Cecka","year":"2002"},{"issue":"12","key":"R2-18-20210129","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1097\/00007890-199812270-00022","article-title":"Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection.","volume":"66","author":"Shoskes","year":"1998","journal-title":"Transplantation"},{"issue":"7","key":"R3-18-20210129","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/00007890-199704150-00011","article-title":"Delayed graft function: risk factors and implications for renal allograft survival.","volume":"63","author":"Ojo","year":"1997","journal-title":"Transplantation"},{"issue":"9","key":"R4-18-20210129","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/00007890-199605150-00008","article-title":"Delayed graft function in the absence of rejection has no long-term impact.","volume":"61","author":"Troppmann","year":"1996","journal-title":"Transplantation"},{"key":"R5-18-20210129","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1681\/ASN.V133769","article-title":"Association of antibody induction with short- and long-term cause-specific mortality in renal transplant recipients.","volume":"13","author":"Meier-Kriesche","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"R6-18-20210129","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00007890-199901270-00016","article-title":"Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group.","volume":"67","author":"Kahan","year":"1999","journal-title":"Transplantation"},{"issue":"1","key":"R7-18-20210129","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00007890-200301150-00007","article-title":"Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody in combination with mycophenolate mofetil-containing triple therapy in renal transplantation.","volume":"75","author":"Lawen","year":"2003","journal-title":"Transplantation"},{"issue":"7","key":"R8-18-20210129","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/00007890-200110150-00014","article-title":"A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients.","volume":"72","author":"Ponticelli","year":"2001","journal-title":"Transplantation"},{"issue":"9","key":"R9-18-20210129","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/00007890-200105150-00017","article-title":"Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation.","volume":"71","author":"Vincenti","year":"2001","journal-title":"Transplantation"},{"key":"R10-18-20210129","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1034\/j.1399-0012.2002.1o078.x","article-title":"Immunosuppression for delayed or slow graft function in primary cadaveric renal transplantation: use of low dose tacrolimus therapy with post-operative administration of anti-CD25 monoclonal antibody.","volume":"16","author":"Gonwa","year":"2002","journal-title":"Clin Transplant"},{"issue":"2","key":"R11-18-20210129","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/00007890-199909150-00018","article-title":"Use of anti-CD25 monoclonal antibody in combination with rapamycin to eliminate cyclosporine treatment during the induction phase of immunosuppression.","volume":"68","author":"Hong","year":"1999","journal-title":"Transplantation"},{"issue":"9","key":"R12-18-20210129","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1097\/00007890-200105150-00025","article-title":"A calcineurin antagonist-free induction strategy for immunosuppression in cadaveric kidney transplant recipients at risk for delayed graft function.","volume":"71","author":"Hong","year":"2001","journal-title":"Transplantation"},{"issue":"suppl 5","key":"R13-18-20210129","first-page":"481","article-title":"Sirolimus and delayed graft function after renal transplantation [abstract].","volume":"3","author":"Knight","year":"2003","journal-title":"Am J Transplant"},{"issue":"5","key":"R14-18-20210129","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/01.TP.0000081042.67285.91","article-title":"A prospective randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients.","volume":"76","author":"Goggins","year":"2003","journal-title":"Transplantation"},{"issue":"suppl 3A","key":"R15-18-20210129","doi-asserted-by":"crossref","first-page":"25S","DOI":"10.1016\/S0041-1345(03)00351-8","article-title":"Ten years of sirolimus therapy for human renal transplantation: The University of Texas at Houston experience.","volume":"35","author":"Kahan","year":"2003","journal-title":"Transplant Proc"},{"key":"R16-18-20210129","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1034\/j.1600-6143.2003.00116.x","article-title":"Sirolimus delays renal allograft recovery.","volume":"3","author":"Davis","year":"2003","journal-title":"Am J Transplant"},{"key":"R17-18-20210129","first-page":"F693","article-title":"Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells.","volume":"281","author":"Lieberthal","year":"2001","journal-title":"Am J Physiol"},{"key":"R18-18-20210129","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1034\/j.1600-6143.2003.00078.x","article-title":"Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation.","volume":"3","author":"McTaggart","year":"2003","journal-title":"Am J Transplant"},{"key":"R19-18-20210129","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/01.ASN.0000057542.86377.5A","article-title":"Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use.","volume":"14","author":"Smith","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"R20-18-20210129","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/00007890-199904150-00017","article-title":"Sirolimus (rapamycin)-based therapy in human renal transplantation.","volume":"67","author":"Groth","year":"1999","journal-title":"Transplantation"},{"key":"R21-18-20210129","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1681\/ASN.V101167","article-title":"Rethinking chronic allograft nephropathy: the concept of accelerated senescence.","volume":"10","author":"Halloran","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R22-18-20210129","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1523-1755.2002.00424.x","article-title":"Post-transplant renal function in the first year predicts long-term kidney transplant survival.","volume":"62","author":"Hariharan","year":"2002","journal-title":"Kidney Int"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007890-200409270-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:29:00Z","timestamp":1785850140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200409270-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,27]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000134399.10352.e4","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9,27]]}}}